Immunogen, Inc.
IMGN
Market Cap$8.73B
Close$
$33.47
7.1% upside
Current Fair Value
7.1% upsideUndervalued by 7.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.73 Billion |
|---|---|
| Enterprise Value | $8.20 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.88 |
| Beta | 1.17 |
| Outstanding Shares | 273,341,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 322.18 |
|---|---|
| PEG | -230.88 |
| Price to Sales | 31.24 |
| Price to Book Ratio | 15.62 |
| Enterprise Value to Revenue | 28.53 |
| Enterprise Value to EBIT | -104.23 |
| Enterprise Value to Net Income | -113 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Immunogen, Inc.
CEO: Mark Enyedy